Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000624916 | SCV000741976 | pathogenic | Inborn genetic diseases | 2017-02-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001386697 | SCV001587035 | pathogenic | not provided | 2023-11-03 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg1081*) in the CDH23 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CDH23 are known to be pathogenic (PMID: 11138009, 21940737). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with deafness (PMID: 20613545). This variant is also known as p.R1086X. ClinVar contains an entry for this variant (Variation ID: 521399). For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV001386697 | SCV002028488 | pathogenic | not provided | 2023-09-18 | criteria provided, single submitter | clinical testing | Identified in a patient with hearing loss in published literature, but patient-specific clinical information was not provided (Kimberling et al., 2010); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 20613545, 35020051) |
Johns Hopkins Genomics, |
RCV001805224 | SCV002051770 | pathogenic | Usher syndrome type 1D | 2021-12-02 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV004568339 | SCV005060196 | pathogenic | Pituitary adenoma 5, multiple types | 2023-11-18 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001834974 | SCV002088040 | pathogenic | Usher syndrome type 1 | 2020-11-23 | no assertion criteria provided | clinical testing |